Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers

By Vandana Singh
January 25, 10:48 AM
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape.

AMZN

Read More
2 minute read
  • General
  • Government
  • Health Care
  • News

Affordable Care Act Enrollment Highest Since Inception: Obamacare Enrollment Witnesses 31% Jump in 2024

By Vandana Singh
January 25, 10:44 AM
Historic milestone in healthcare: 21.3M Americans enroll in Obamacare, a 31% increase from last year. Act now, open enrollment persists in select states until January 31.

ALHC

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

What’s Going On With Pfizer Stock Today?

By Vandana Singh
January 25, 10:26 AM
Pfizer to announce Q4 2023 earnings on 30th Jan. Analysts project EPS loss of $(0.22) and $14.25B in revenues.

DSKYF

Read More
3 minute read
  • Cannabis
  • Health Care
  • Psychedelics
  • Top Stories

New Study Reveals Suggestibility’s Role In Antidepressant Effects Of Psilocybin Therapy

By Lara Goldstein
January 25, 10:03 AM
Study found that suggestibility did not predict response to psilocybin therapy for MDD patients, challenging concerns about placebo effects.

CMPS

Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook

By Vandana Singh
January 25, 9:22 AM
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion.

CI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Downgrades
  • Equities
  • General
  • Health Care
  • News
  • Price Target
  • Trading Ideas

Slow Market Penetration For Biogen’s Another Alzheimer’s Drug: UBS Highlights Risks, Forecasts

By Vandana Singh
January 24, 3:55 PM
UBS insights on Biogen Inc's challenges with Leqembi in the Alzheimer's market. Analyst downgrades, revised sales estimates, and CEO's growth strategy.

BIIB

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

Weight Loss Drug’s Ozempic Counterfeit: Rising Reports Over Patient Safety Related Fake Drugs

By Vandana Singh
January 24, 3:21 PM
Discover the alarming rise in fake Ozempic cases, leading to hypoglycemia. Learn about FDA investigations, counterfeit warnings, and the surge in reports.

LLY

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News

Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?

By Vandana Singh
January 24, 3:08 PM
Evaxion Biotech revolutionizes cancer vaccine development, targeting AI-identified ERVs. Preclinical activities underway; Proof-of-Concept data expected by 2H 2024.

EVAX

Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Topics
  • Trading Ideas

Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand

By Vandana Singh
January 24, 1:34 PM
Abbott Laboratories exceeds expectations with Q4 sales of $10.24B, showcasing resilience despite softer demand for COVID-19 testing. CEO anticipates continued growth in 2024.

ABT

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Heron Therapeutics’ Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures – FDA Gives Nod

By Vandana Singh
January 24, 12:47 PM
Zynrelef's expanded FDA approval for soft tissue and orthopedic surgeries, offering superior pain management with lower pain scores and opioid consumption.

HRTX

Posts pagination

Previous 1 … 71 72 73 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service